BBHC
EW icon

Brown Brothers Harriman & Co’s Edwards Lifesciences EW Stock Holding History

Brown Brothers Harriman & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
20,292
+9,194
+83% +$770K 0.01% 380
2026
Q1 		$889K Buy
11,098
+6,206
+127% +$512K ﹤0.01% 457
2025
Q4 		$417K Buy
4,892
+2,999
+158% +$246K ﹤0.01% 585
2025
Q3 		$147K Buy
1,893
+327
+21% +$25.5K ﹤0.01% 769
2025
Q2 		$122K Buy
1,566
+885
+130% +$66K ﹤0.01% 743
2025
Q1 		$49.4K Sell
681
-502
-42% -$35.9K ﹤0.01% 843
2024
Q4 		$87.6K Buy
1,183
+177
+18% +$12.4K ﹤0.01% 748
2024
Q3 		$66.4K Buy
1,006
+46
+5% +$3.34K ﹤0.01% 762
2024
Q2 		$88.7K Sell
960
-254
-21% -$22.5K ﹤0.01% 679
2024
Q1 		$116K Sell
1,214
-163
-12% -$13.7K ﹤0.01% 620
2023
Q4 		$105K Sell
1,377
-210
-13% -$14.6K ﹤0.01% 610
2023
Q3 		$110K Sell
1,587
-242
-13% -$19.4K ﹤0.01% 577
2023
Q2 		$173K Buy
1,829
+501
+38% +$43.5K ﹤0.01% 506
2023
Q1 		$110K Buy
1,328
+315
+31% +$24.8K ﹤0.01% 591
2022
Q4 		$75.6K Sell
1,013
-12
-1% -$925 ﹤0.01% 650
2022
Q3 		$85K Buy
1,025
+340
+50% +$32.7K ﹤0.01% 631
2022
Q2 		$65K Buy
685
+138
+25% +$14.3K ﹤0.01% 659
2022
Q1 		$64K Sell
547
-400
-42% -$44.9K ﹤0.01% 720
2021
Q4 		$123 Sell
947
-827
-47% -$96.5K ﹤0.01% 560
2021
Q3 		$201 Buy
1,774
+842
+90% +$96.1K ﹤0.01% 456
2021
Q2 		$97 Sell
932
-85
-8% -$8.01K ﹤0.01% 560
2021
Q1 		$85 Buy
1,017
+21
+2% +$1.77K ﹤0.01% 547
2020
Q4 		$91K Buy
996
+645
+184% +$53.5K ﹤0.01% 570
2020
Q3 		$28K Buy
351
+6
+2% +$468 ﹤0.01% 644
2020
Q2 		$24K Buy
345
+18
+6% +$1.28K ﹤0.01% 661
2020
Q1 		$21K Sell
327
-432
-57% -$31.2K ﹤0.01% 627
2019
Q4 		$59K Hold
759
– – ﹤0.01% 635
2019
Q3 		$56K Buy
759
+168
+28% +$11.8K ﹤0.01% 627
2019
Q2 		$36K Buy
591
+57
+11% +$3.45K ﹤0.01% 645
2019
Q1 		$34K Buy
534
+291
+120% +$16.6K ﹤0.01% 645
2018
Q4 		$12K Buy
243
+150
+161% +$7.59K ﹤0.01% 674
2018
Q3 		$5K Sell
93
-84
-47% -$4.11K ﹤0.01% 749
2018
Q2 		$9K Sell
177
-333
-65% -$15.5K ﹤0.01% 672
2018
Q1 		$24K Sell
510
-696
-58% -$30.2K ﹤0.01% 560
2017
Q4 		$45K Buy
1,206
+531
+79% +$19.5K ﹤0.01% 526
2017
Q3 		$25K Hold
675
– – ﹤0.01% 563
2017
Q2 		$27K Hold
675
– – ﹤0.01% 553
2017
Q1 		$21K Sell
675
-1,050
-61% -$32.9K ﹤0.01% 584
2016
Q4 		$54K Hold
1,725
– – ﹤0.01% 476
2016
Q3 		$69K Sell
1,725
-1,725
-50% -$65K ﹤0.01% 412
2016
Q2 		$115K Sell
3,450
-4,950
-59% -$169K ﹤0.01% 368
2016
Q1 		$247K Hold
8,400
– – ﹤0.01% 287
2015
Q4 		$221K Hold
8,400
– – ﹤0.01% 314
2015
Q3 		$199K Hold
8,400
– – ﹤0.01% 325
2015
Q2 		$199K Buy
+8,400
New +$190K ﹤0.01% 335
2013
Q4 		– Sell
-12,210
Closed -$142K – 664
2013
Q3 		$142K Sell
12,210
-91,272
-88% -$1.07M ﹤0.01% 350
2013
Q2 		$1.16M Buy
+103,482
New +$1.22M 0.01% 209

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Brown Brothers Harriman & Co's EW Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Edwards Lifesciences (EW) stake by 83% in Q2 2026, buying an estimated $770K and bringing the position to 20,292 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #380.

Brown Brothers Harriman & Co first reported a position in EW in Q2 2013 and has held it in 47 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Brown Brothers Harriman & Co held 20,292 shares of Edwards Lifesciences worth $1.84M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 9,194 Edwards Lifesciences shares in Q2 2026, an estimated $770K.
  • Edwards Lifesciences made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #380 holding.
  • Brown Brothers Harriman & Co first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 47 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.